Ransomware Attack on a Major Health Tech Firm Slows Down Several COVID-19 Clinical Trials

Alicia Hope reports:

A ransomware attack targeting medical technology firm slowed down clinical trials for the past two weeks, according to the New York Times. The attack targeted a Philadelphia company that develops software for clinical trials, including the crash effort to develop rapid coronavirus tests, treatment, and the vaccine. The attack on eResearch Technology forced clinicians to track their patients with pen and paper after locking the researchers out of their data.

Read more on CPO Magazine.

About the author: Dissent

Comments are closed.